Ambica Agarbathies Aroma & Industries Past Earnings Performance
Past criteria checks 0/6
Ambica Agarbathies Aroma & Industries's earnings have been declining at an average annual rate of -55%, while the Chemicals industry saw earnings growing at 15.1% annually. Revenues have been declining at an average rate of 8.7% per year.
Key information
-55.0%
Earnings growth rate
-54.4%
EPS growth rate
| Chemicals Industry Growth | 17.7% |
| Revenue growth rate | -8.7% |
| Return on equity | -3.6% |
| Net Margin | -3.7% |
| Next Earnings Update | 14 Aug 2024 |
Recent past performance updates
Recent updates
Ambica Agarbathies Aroma & Industries' (NSE:AMBICAAGAR) Returns On Capital Tell Us There Is Reason To Feel Uneasy
Aug 13
Returns Are Gaining Momentum At Ambica Agarbathies Aroma & Industries (NSE:AMBICAAGAR)
Mar 15Ambica Agarbathies Aroma & Industries (NSE:AMBICAAGAR) Has A Somewhat Strained Balance Sheet
Feb 01We Ran A Stock Scan For Earnings Growth And Ambica Agarbathies Aroma & Industries (NSE:AMBICAAGAR) Passed With Ease
Oct 12Calculating The Intrinsic Value Of Ambica Agarbathies Aroma & Industries Limited (NSE:AMBICAAGAR)
Aug 29Returns On Capital Are Showing Encouraging Signs At Ambica Agarbathies Aroma & Industries (NSE:AMBICAAGAR)
Jun 08Investors Could Be Concerned With Ambica Agarbathies Aroma & Industries' (NSE:AMBICAAGAR) Returns On Capital
Dec 26Here's What's Concerning About Ambica Agarbathies Aroma & Industries' (NSE:AMBICAAGAR) Returns On Capital
Sep 02Some Investors May Be Worried About Ambica Agarbathies Aroma & Industries' (NSE:AMBICAAGAR) Returns On Capital
May 07Calculating The Intrinsic Value Of Ambica Agarbathies Aroma & Industries Limited (NSE:AMBICAAGAR)
Feb 11There's No Escaping Ambica Agarbathies Aroma & Industries Limited's (NSE:AMBICAAGAR) Muted Earnings Despite A 44% Share Price Rise
Oct 07Revenue & Expenses Breakdown
How Ambica Agarbathies Aroma & Industries makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 978 | -37 | 43 | 0 |
| 31 Dec 23 | 1,097 | -21 | 79 | 0 |
| 30 Sep 23 | 1,127 | 3 | 73 | 0 |
| 30 Jun 23 | 1,176 | 29 | 30 | 0 |
| 31 Mar 23 | 1,172 | 25 | 69 | 0 |
| 31 Dec 22 | 1,225 | 23 | 56 | 0 |
| 30 Sep 22 | 1,193 | 9 | 57 | 0 |
| 30 Jun 22 | 1,181 | 4 | 55 | 0 |
| 31 Mar 22 | 1,163 | 24 | 55 | 0 |
| 31 Dec 21 | 1,146 | 44 | 51 | 0 |
| 30 Sep 21 | 1,157 | 36 | 35 | 0 |
| 30 Jun 21 | 1,249 | 28 | 40 | 0 |
| 31 Mar 21 | 1,434 | 27 | 65 | 0 |
| 31 Dec 20 | 1,727 | 20 | 85 | 0 |
| 30 Sep 20 | 1,765 | 2 | 90 | 0 |
| 30 Jun 20 | 1,724 | 10 | 92 | 0 |
| 31 Mar 20 | 1,675 | 43 | 95 | 0 |
| 31 Dec 19 | 1,518 | 87 | 95 | 0 |
| 30 Sep 19 | 1,481 | 129 | 92 | 0 |
| 30 Jun 19 | 1,428 | 130 | 52 | 0 |
| 31 Mar 19 | 1,382 | 102 | 92 | 0 |
| 31 Dec 18 | 1,275 | -158 | 88 | 0 |
| 30 Sep 18 | 1,267 | -175 | 83 | 0 |
| 30 Jun 18 | 1,268 | -178 | 51 | 0 |
| 31 Mar 18 | 1,254 | -178 | 76 | 0 |
| 31 Dec 17 | 1,214 | 11 | 49 | 0 |
| 30 Sep 17 | 1,208 | 16 | 52 | 0 |
| 30 Jun 17 | 1,192 | 15 | 55 | 0 |
| 31 Mar 17 | 1,192 | 15 | 60 | 0 |
| 31 Dec 16 | 1,101 | 11 | 84 | 0 |
| 30 Sep 16 | 1,138 | 13 | 85 | 0 |
| 30 Jun 16 | 1,143 | 13 | 86 | 0 |
| 31 Mar 16 | 1,158 | 13 | 86 | 0 |
| 31 Dec 15 | 1,137 | 22 | 75 | 0 |
| 30 Sep 15 | 1,125 | 12 | 42 | 0 |
| 30 Jun 15 | 1,150 | 14 | 41 | 0 |
| 31 Mar 15 | 1,157 | 14 | 72 | 0 |
| 31 Dec 14 | 1,150 | 15 | 37 | 0 |
| 30 Sep 14 | 1,157 | 11 | 32 | 0 |
| 30 Jun 14 | 1,141 | 14 | 32 | 0 |
| 31 Mar 14 | 1,120 | 11 | 61 | 0 |
| 31 Dec 13 | 1,108 | 4 | 209 | 0 |
| 30 Sep 13 | 1,066 | 11 | 207 | 0 |
Quality Earnings: AMBICAAGAR is currently unprofitable.
Growing Profit Margin: AMBICAAGAR is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AMBICAAGAR is unprofitable, and losses have increased over the past 5 years at a rate of 55% per year.
Accelerating Growth: Unable to compare AMBICAAGAR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: AMBICAAGAR is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (7.6%).
Return on Equity
High ROE: AMBICAAGAR has a negative Return on Equity (-3.6%), as it is currently unprofitable.